TC Biopharm has a total of 80 patents globally, out of which 20 have been granted. Of these 80 patents, more than 57% patents are active. The United Kingdom is where TC Biopharm has filed the maximum number of patents, followed by Japan and United States of America. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of TC Biopharm.
TC Biopharm was founded in 2014. TC Biopharm operates as a clinical-stage cell therapy company. The company develops safer, cheaper, consistent, and durable CAR-T drugs for haematological and solid tumours. As of May 2023, the market cap of TC Biopharm is $2.40 Million.
Do read about some of the most popular patents of TC Biopharm which have been covered by us in this article and also you can find TC Biopharm patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over TC Biopharm patent portfolio.
How many patents do the Founder and CEO of TC Biopharm have?
The Founder Angela Scott, Artin Moussavi, David Gallagher, Michael Leek have 0, 19, 8, 19 patents and CEO Bryan Kobel have 0 patents.
How many patents does TC Biopharm have?
TC Biopharm has a total of 80 patents globally. These patents belong to 20 unique patent families. Out of 80 patents, 46 patents are active.
How Many Patents did TC Biopharm File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||TC Biopharm Applications Filed||TC Biopharm Patents Granted|
How many TC Biopharm patents are Alive/Dead?
How Many Patents did TC Biopharm File in Different Countries?
Countries in which TC Biopharm Filed Patents
|United States Of America||6|
|Hong Kong (S.A.R.)||3|
Where are Research Centers of TC Biopharm Patents Located?
The Research Centers of TC Biopharm Patents is the United Kingdom.
10 Best TC Biopharm Patents
WO2016166544A1 is the most popular patent in the TC Biopharm portfolio. It has received 29 citations so far from companies like Adaptate Biotherapeutics, Immatics, Gammadelta Therapeutics.
Below is the list of 10 most cited patents of TC Biopharm:
|Publication Number||Citation Count|
What Percentage of TC Biopharm US Patent Applications were Granted?
TC Biopharm (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 50%.
Below are the key stats of TC Biopharm patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for TC Biopharm?
|Law Firm||Total Applications||Success Rate|
|Alston & Bird||4||100%|
|Faegre Drinker Biddle & Reath||1||0%|